Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Matthew Mintz
The Long-Term Impact of COVID-19 on the Pharma Sales Model
Half of my career has been in sales and the other in marketing. I have always had a strong affiliation to the sales team because as a marketer, I relied on them to execute the plan that they helped me draw up. My past mentors and other marketing authors call this Smarketing. So, this is a good time to reflect on what the long-term impact of COVID-19 may be on the pharma sales model and why a Smarketing approach is more important than ever.
Reducing the Risk of Mortality in Chronic Obstructive Pulmonary Disease With Pharmacotherapy: A Narrative Review
Adeloye D. Chua S. Lee C. et al. Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health. 2015; 5020415 Xie M. Liu X. Cao X. Guo M. Li X. Trends in prevalence and incidence of chronic respiratory diseases from 1990 to 2017. Respir Res. 2020; 21: 49 Ahmad FB, Cisewski JA, Minino A, Anderson RN. Provisional mortality data—United States, 2020. MMWR Morb Mortal Wkly Rep. 2021;70(14):519-522. Published correction appears in MMWR Morb Mortal Wkly Rep. 2021;70(24):900.
The Future of HCP Engagement is Digital
Reaching and engaging healthcare professionals (HCPs) used to be straightforward. Pharmaceutical field forces called on physicians, educated them about new therapies, and distributed samples. Pharma companies would then connect those face-to-face meetings to resulting prescription sales. Today’s landscape looks very different. This year, COVID-19 accelerated the trend away from face-to-face meetings.
Industry Briefs November 2020
Prognos Health Launches Analytics Platform A leader in clinically focused healthcare analytics, Prognos Health launched an integrated healthcare analytics platform that transforms the way pharmaceutical companies, providers, and payers receive and analyze healthcare data.
Is Empagliflozin a Diabetes 'Game Changer'?
Do Prescribing Trends Foretell the Future? When a new version of inhaled insulin was approved less than 2 years ago, it had the potential to become a major component of diabetes treatment. However, given the recent announcement that pharmaceutical giant Sanofi will stop distributing Afrezza® after a year of poor sales, it is unlikely that the product developed by Mannkind will change the diabetes landscape.
Experiential Learning Evolved-Using VR/AR for Patient and HCP Education
Learning by doing is not a new concept—the theory has been around for centuries. It was expounded by John Dewey in the early 1900s and again in the 1980s by David Kolb with his theory of experiential learning. Today, the value of learning through experience, rather than passively receiving information, is considered obvious—you don’t learn how to ride a bike by sitting in a classroom.
Three Tips for Creating Better Product Usability
When designing a product, website, platform, or other experience, consider these three tips to ensure the best usability for your customers. 1. Don’t skip the research Understanding customers and their challenges leads to creating the best product. The development team should list the information and customer access that is available and create a plan that helps support ongoing research.
Physician Opinions About “Fair” Prices Vary for Certain Therapies
As the cost of pharmaceutical and biotechnology therapies continues to rise, concern about the ability of healthcare systems to afford high-cost therapies is accelerating. Policymakers have recently proposed initiatives to try to address the issue, including mandated price negotiations and limits on price increases. Concurrently, manufacturers highlight the high cost of clinical trials and the risks they assume in developing innovative therapies and the need to recoup the cost of their investment.
Survey of NPs and PAs Reveal How Pharma Can Offer More Support During COVID
For many nurse practitioners (NPs) and physician assistants (PAs), the COVID-19 pandemic led to new and increasing responsibility. That also means they can offer critical insights into how pharma can help them to better serve patients during this time.
COVID-19: Optimism Tempered by New Concerns for U.S. Frontline Treating Physicians
The implications of the COVID-19 pandemic are uniquely understood by frontline treating physicians. In the fourth wave of a COVID-19 tracking report on U.S. frontline treating physicians, from real-time life sciences market insights provider InCrowd, this important clinical community shared newfound optimism around preparedness and the ability to “flatten the curve,” along with surprising new concerns.
5 Strategies to Reach Today’s Always Busy Physicians
Our phones have evolved from helpful tools, into smart devices that are now integral to a physician’s day-to-day work. For most doctors, there’s rarely a moment in the day when we aren’t checking our phones for updates, or at least, have a device nearby. Often, more than one. This new reality requires that healthcare marketers adopt a digital-first attitude if they want to reach their intended physician audience.
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Matthew
Contact Matthew, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack